|
1
|
Dutton JJ: Optic nerve sheath meningiomas.
Surv Ophthalmol. 37:167–183. 1992.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Parker RT, Ovens CA, Fraser CL and
Samarawickrama C: Optic nerve sheath meningiomas: Prevalence,
impact, and management strategies. Eye Brain. 10:85–99.
2018.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Carbone L, Somma T, Iorio GG, Vitulli F,
Conforti A, Raffone A, Bove I, Pagano S, Pontillo M, Carbone IF, et
al: Meningioma during pregnancy: What can influence the management?
A case series and review of the literature. J Matern Fetal Neonatal
Med. 35:8767–8777. 2022.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Chakravarthy V, Kaplan B, Gospodarev V,
Myers H, De Los Reyes K and Achiriloaie A: Houdini tumor: Case
report and literature review of pregnancy-associated meningioma.
World Neurosurg. 114:e1261–e1265. 2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Iplikcioglu AC, Hatiboglu MA, Ozek E and
Ozcan D: Is progesteron receptor status really a prognostic factor
for intracranial meningiomas? Clin Neurol Neurosurg. 124:119–122.
2014.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Lusis EA, Scheithauer BW, Yachnis AT,
Fischer BR, Chicoine MR, Paulus W and Perry A: Meningiomas in
pregnancy: A clinicopathologic study of 17 cases. Neurosurgery.
71:951–961. 2012.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Pravdenkova S, Al-Mefty O, Sawyer J and
Husain M: Progesterone and estrogen receptors: Opposing prognostic
indicators in meningiomas. J Neurosurg. 105:163–173.
2006.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Hatiboglu MA, Cosar M, Iplikcioglu AC and
Ozcan D: Sex steroid and epidermal growth factor profile of giant
meningiomas associated with pregnancy. Surg Neurol. 69:356–362;
discussion 362-3. 2008.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Smith JS, Quinones-Hinojosa A,
Harmon-Smith M, Bollen AW and McDermott MW: Sex steroid and growth
factor profile of a meningioma associated with pregnancy. Can J
Neurol Sci. 32:122–127. 2005.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Giraldi L, Lauridsen EK, Maier AD, Hansen
JV, Broholm H, Fugleholm K, Scheie D and Munch TN: Pathologic
characteristics of pregnancy-related meningiomas. Cancers (Basel).
13(3879)2021.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Nossek E, Ekstein M, Barkay G, Shahar T,
Gonen L, Rimon E, Kesler A and Margalit N: Visual deterioration
during pregnancy due to skull base tumors compressing the optic
apparatus. Neurosurg Rev. 38:473–479; discussion 479.
2015.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Hannon AM, Frizelle I, Kaar G, Hunter SJ,
Sherlock M, Thompson CJ and O'Halloran DJ: Irish Pituitary Database
Group. Octreotide use for rescue of vision in a pregnant patient
with acromegaly. Endocrinol Diabetes Metab Case Rep. 2019:19–0019.
2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Johnson N, Sermer M, Lausman A and Maxwell
C: Obstetric outcomes of women with intracranial neoplasms. Int J
Gynaecol Obstet. 105:56–59. 2009.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Moscovici S, Fraifeld S, Cohen JE, Dotan
S, Elchalal U, Shoshan Y and Spektor S: Parasellar meningiomas in
pregnancy: Surgical results and visual outcomes. World Neurosurg.
82:e503–e512. 2014.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Sugo N, Yokota K, Nemoto M, Hatori T, Kano
T, Goto S and Seiki Y: Accelerated growth of an orbital schwannoma
during pregnancy. J Neuroophthalmol. 27:45–47. 2007.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Chacko JG, Miller JL and Angtuaco EJ:
Spontaneous postpartum resolution of vision loss caused by a
progesterone receptor-positive tuberculum sellae meningioma. J
Neuroophthalmol. 30:132–134. 2010.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Kerschbaumer J, Freyschlag CF, Stockhammer
G, Taucher S, Maier H, Thomé C and Seiz-Rosenhagen M:
Hormone-dependent shrinkage of a sphenoid wing meningioma after
pregnancy: Case report. J Neurosurg. 124:137–140. 2016.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Miller NR: New concepts in the diagnosis
and management of optic nerve sheath meningioma. J Neuroophthalmol.
26:200–208. 2006.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Douglas VP, Douglas KAA and Cestari DM:
Optic nerve sheath meningioma. Curr Opin Ophthalmol. 31:455–461.
2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Turbin RE, Wladis EJ, Frohman LP, Langer
PD and Kennerdell JS: Role for surgery as adjuvant therapy in optic
nerve sheath meningioma. Ophthalmic Plast Reconstr Surg.
22:278–282. 2006.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Turbin RE, Thompson CR, Kennerdell JS,
Cockerham KP and Kupersmith MJ: A long-term visual outcome
comparison in patients with optic nerve sheath meningioma managed
with observation, surgery, radiotherapy, or surgery and
radiotherapy. Ophthalmology. 109:890–899; discussion 899-900.
2002.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Inoue T, Mimura O, Ikenaga K, Okuno Y and
Nishiguchi I: The rapid improvement in visual field defect observed
with weekly perimetry during intensity-modulated radiotherapy for
optic nerve sheath meningioma. Int Cancer Conf J. 8:136–140.
2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Liu D, Xu D, Zhang Z, Zhang Y, Li Y, Liu
X, Jia Q, Zheng L and Song G: Long-term results of Gamma Knife
surgery for optic nerve sheath meningioma. J Neurosurg. 113
(Suppl):S28–S33. 2010.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Sasano H, Shikishima K, Aoki M, Sakai T,
Tsutsumi Y and Nakano T: Efficacy of intensity-modulated radiation
therapy for optic nerve sheath meningioma. Graefes Arch Clin Exp
Ophthalmol. 257:2297–2306. 2019.PubMed/NCBI View Article : Google Scholar
|
